首页> 外文会议>International Photodynamic Association World Congress >Assessment of the analgesic effect of compound lidocaine cream in patients with port-wine stain treated by Hemoporfin Photodynamic Therapy
【24h】

Assessment of the analgesic effect of compound lidocaine cream in patients with port-wine stain treated by Hemoporfin Photodynamic Therapy

机译:用血红病光动力疗法治疗复合利多卡内乳膏患者镇痛作用的评估

获取原文

摘要

Background Port-wine stain (PWS) is a congenital vascular malformation, frequently appearing at the face and neck. Hemoporfin photodynamic therapy (HMME-PDT) is a new technology for treating PWS. Pain is one of the major and intractable side-effects in this treatment. Compound lidocaine cream is widely utilized for local anaesthesia for good curative effect. Objectives To investigate the degree of pain in the patients treated by HMME-PDT and evaluate the analgesia effects of compound lidocaine cream. Methods Patients were divided into two groups randomly. For treatment group, the compound lidocaine cream with the dose of 2g/cm~2 was occluded for 2 hours before treatment, and placebo for control group. We used ChangHai rating scale to record pain scores every minute during the treatment. Results 78 patients were included and divided into test group and control group. Pain occured at the beginning of treatment and increased in the first 16 minutes by time, then stabilized. There was a significant difference between the two groups about the association of pain and treatment time (P < 0.05), but no significant difference of pain scores at each minute(P < 0.05). Different factors such as location, size and types of lesion were compared and showed no significant difference of pain scores. Conclusions From this trial, we found that the pain during treatment started at the beginning and got worse in the first 16 minutes by time, then stabilized. Accordingly, compound lidocaine cream could not release the pain during treatment.
机译:背景技术葡萄酒污渍(PWS)是先天性血管畸形,经常出现在脸部和颈部。血管素光学动力学治疗(HMME-PDT)是一种治疗PWS的新技术。疼痛是这种治疗中的主要和难治性副作用之一。复合利多卡因乳膏广泛用于局部麻醉,良好的疗效。目的探讨HMME-PDT治疗患者疼痛程度,评价复合利多卡因霜的镇痛作用。方法患者随机分为两组。对于治疗组,在处理前2小时堵塞具有剂量为2g / cm〜2的化合物利多卡因乳膏,对照组安慰剂。我们利用长海评级规模每分钟在治疗过程中记录疼痛分数。结果包括78名患者,并分为试验组和对照组。在治疗开始时疼痛发生,并且在前16分钟的时间内增加,然后稳定。两组关于疼痛和治疗时间结合的两组之间存在显着差异(P <0.05),但每分钟疼痛评分没有显着差异(P <0.05)。比较不同的因素,如位置,大小和类型的病变,并显示出疼痛评分没有显着差异。结论来自该试验,我们发现治疗期间的疼痛在开始时开始,在前16分钟逐步变得更糟,然后稳定。因此,复合利多卡因霜在治疗过程中不能释放疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号